Peter James Fredericks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Peter James Fredericks has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Brendan Saloner
Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University , 615 N Wolfe St, Baltimore, MD 21205, United States
1 shared publication - Cindy Parks Thomas
Heller School for Social Policy and Management Brandeis University Waltham Massachusetts USA
1 shared publication - Jirka Taylor
Department of Health Policy and Management, Bloomberg School of Public Health Johns Hopkins University Baltimore MD USA
1 shared publication - Karen Shen
Johns Hopkins University Department of Health Policy and Management Baltimore, MD 21205
1 shared publication - Sachini Bandara
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
1 shared publication
Latest Publications
- Open Access
- 30 April 2025
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 3 (5)
Predictors of non-transport by emergency medical services after a nonfatal opioid overdose: a national analysis
Introduction: Emergency medical services (EMS) response to nonfatal overdoses represents an opportunity to provide linkage to services. However, patients may decline follow-on transportation. This paper examined predictors associated with non-transport after nonfatal opioid overdoses. Methods: We undertook a cross-sectional analysis of 2021-2022 data from the National EMS Information System. The outcome was a binary measure of declined transport. Predictors included age, gender, race/ethnicity, response time, EMS level of care, naloxone does, setting, urbanicity, region, time, and day. Results: We identified 710 263 nonfatal opioid overdose events, of which 12.4% ended in non-transport. Men were more likely to decline transport (average marginal effect [AME] 0.020 [95% CI, 0.019-0.022]), and Black patients were less likely to decline (AME −0.022 [95% CI, −0.024 to −0.021]). Compared with events involving an EMS-administered limited first dose (<2 mg), non-transports were more likely in events without naloxone administration (AME 0.075 [95% CI, 0.073-0.078]), with administration only by laypersons (AME 0.101 [95% CI, 0.096-0.107]), and when EMS administered higher first doses (2-4 mg AME 0.039 [95% CI, 0.037-0.041]; 4 mg+ AME 0.053 [95% CI, 0.049-0.056]). Conclusion: Efforts to improve post-overdose care should focus on groups who are more likely to decline transport and on appropriate naloxone dosing.
- 30 April 2025
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 3 (5)
Open AccessPredictors of non-transport by emergency medical services after a nonfatal opioid overdose: a national analysis
Introduction: Emergency medical services (EMS) response to nonfatal overdoses represents an opportunity to provide linkage to services. However, patients may decline follow-on transportation. This paper examined predictors associated with non-transport after nonfatal opioid overdoses. Methods: We undertook a cross-sectional analysis of 2021-2022 data from the National EMS Information System. The outcome was a binary measure of declined transport. Predictors included age, gender, race/ethnicity, response time, EMS level of care, naloxone does, setting, urbanicity, region, time, and day. Results: We identified 710 263 nonfatal opioid overdose events, of which 12.4% ended in non-transport. Men were more likely to decline transport (average marginal effect [AME] 0.020 [95% CI, 0.019-0.022]), and Black patients were less likely to decline (AME −0.022 [95% CI, −0.024 to −0.021]). Compared with events involving an EMS-administered limited first dose (<2 mg), non-transports were more likely in events without naloxone administration (AME 0.075 [95% CI, 0.073-0.078]), with administration only by laypersons (AME 0.101 [95% CI, 0.096-0.107]), and when EMS administered higher first doses (2-4 mg AME 0.039 [95% CI, 0.037-0.041]; 4 mg+ AME 0.053 [95% CI, 0.049-0.056]). Conclusion: Efforts to improve post-overdose care should focus on groups who are more likely to decline transport and on appropriate naloxone dosing.